US 11590156
RNAi agents for hepatitis B virus infection
granted A61KA61K31/675A61K31/7088
Quick answer
US patent 11590156 (RNAi agents for hepatitis B virus infection) held by Arrowhead Pharmaceuticals, Inc. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/675, A61K31/7088, A61K31/7105, A61K9/0019